Literature DB >> 25936311

Effects of different lipoprotein apheresis methods on serum protein levels.

U Julius1, G Siegert2, H Kostka2, U Schatz3, B Hohenstein3.   

Abstract

BACKGROUND: A total plasma exchange was the first extracorporeal method to treat patients with severe hypercholesterolemia. But in the long run it has several disadvantages. The newer lipoprotein apheresis (LA) methods claim to be more selective with respect to the removal of atherogenic lipoproteins and thus are supposed to avoid an additional protein loss.
METHODS: We wanted to compare the effect of these methods on serum protein concentrations (total serum protein, albumin, proteins measured with electrophoresis, immunoglobulins, fibrinogen, transferrin, and ferritin) which were checked before and after a single LA session in 75 patients. All patients underwent active LA treatment using 6 different LA methods (HELP, TheraSorb(®) LDL, DALI, Lipidfiltration, Liposorber D, MONET). Post-apheresis concentrations were corrected for changes in hematocrit.
RESULTS: The slightest impact on total serum protein was observed with the whole-blood methods. Liposorber D showed the least reduction of albumin levels. All LA methods had a small effect on alpha1-globulins and beta-globulins, but alpha2-and gamma-globulins were reduced to a different extent. A major effect was seen on the immunoglobulins when filtration methods were applied. In the patients treated with MONET, both pre- and post-apheresis Immunoglobulin M concentrations were below the normal range. HELP and the filtration methods significantly reduced the fibrinogen concentrations. The filtration methods also decreased ferritin levels but the post-apheresis ferritin levels were still in the normal range.
CONCLUSION: All LA methods had an influence on protein concentrations. At present, these findings will not yield an individualized treatment approach for any selective LA method due to the lack of prospective comparative studies. At minimum, special attention should be paid to protein concentrations in patients suffering from protein deficit.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Albumin; Ferritin; Fibrinogen; Immunoglobulins; Lipoprotein apheresis; Total serum protein; Transferrin

Mesh:

Substances:

Year:  2015        PMID: 25936311     DOI: 10.1016/j.atherosclerosissup.2015.02.018

Source DB:  PubMed          Journal:  Atheroscler Suppl        ISSN: 1567-5688            Impact factor:   3.235


  5 in total

Review 1.  [Lipoprotein apheresis : State of the art and case report of the longest HELP treatment worldwide].

Authors:  Adrienn Tünnemann-Tarr; Julius Ludwig Katzmann; Joachim Thiery; Ulrich Laufs
Journal:  Herz       Date:  2022-04-22       Impact factor: 1.443

2.  Low-density lipoprotein apheresis is associated with removal of SARS-CoV-2 antibodies.

Authors:  Sebastian Bertram; Thiemo Pfab; Christian Albert; Sven Schmidt; Jürgen Passfall; Martin Haesner; Maximilian Seidel; Bodo Hölzer; Felix S Seibert; Adrian Doevelaar; Benjamin Rohn; Panagiota Zgoura; Nina Babel; Timm H Westhoff
Journal:  Ther Apher Dial       Date:  2022-03-29       Impact factor: 2.195

Review 3.  Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection.

Authors:  Ulrich Julius
Journal:  Med Devices (Auckl)       Date:  2016-10-13

4.  Improvement of oxidative stress status by lipoprotein apheresis in Chinese patients with familial hypercholesterolemia.

Authors:  Jun Wen; Qian Dong; Geng Liu; Ying Gao; Xiao-Lin Li; Jing-Lu Jin; Jian-Jun Li; Yuan-Lin Guo
Journal:  J Clin Lab Anal       Date:  2019-12-20       Impact factor: 2.352

Review 5.  Current Role of Lipoprotein Apheresis in the Treatment of High-Risk Patients.

Authors:  Ulrich Julius
Journal:  J Cardiovasc Dev Dis       Date:  2018-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.